Transgene Announces Upcoming Investor Meetings
18 Marzo 2024 - 10:45AM
Transgene Announces Upcoming Investor Meetings
Strasbourg, March 18, 2024 - 05:45 pm CET
TRANSGENE (Paris: TNG) today
announces that Management will participate in several investor
events in the upcoming months, as set out below.
- Investor Access Event (Paris, France): April
5, 2024,
- Van Lanschot Kempen Life Sciences Conference
(Amsterdam, Netherlands): April 16, 2024,
- Oddo BHF Nextcap Forum (virtual): June 6,
2024.
Contacts
Transgene:Lucie Larguier +33 (0)3 88 27 91
04investorrelations@transgene.fr |
Media:
MEDiSTRAVA ConsultingFrazer Hall/Sylvie Berrebi+44 (0)203
928 6900transgene@medistrava.com |
About Transgene
Transgene (Euronext: TNG) is a biotechnology
company focused on designing and developing targeted
immunotherapies for the treatment of cancer. Transgene’s programs
utilize viral vector technology with the goal of indirectly or
directly killing cancer cells. The Company’s clinical-stage
programs consist of a portfolio of therapeutic vaccines and
oncolytic viruses: TG4050, the first individualized therapeutic
vaccine based on the myvac® platform, TG4001 for the treatment of
HPV-positive cancers, as well as TG6050 and BT-001, two oncolytic
viruses based on the Invir.IO® viral backbone. With Transgene’s
myvac® platform, therapeutic vaccination enters the field of
precision medicine with a novel immunotherapy that is fully
tailored to each individual. The myvac® approach allows the
generation of a virus-based immunotherapy that encodes
patient-specific mutations identified and selected by Artificial
Intelligence capabilities provided by its partner NEC. With its
proprietary platform Invir.IO®, Transgene is building on its viral
vector engineering expertise to design a new generation of
multifunctional oncolytic viruses.Additional information about
Transgene is available at: www.transgene.frFollow us on social
media: X (formerly Twitter): @TransgeneSA – LinkedIn:
@Transgene
- 20240318-Transgene-investor-meetings-spring-2024-EN
Transgene (EU:TNG)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Transgene (EU:TNG)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024